Ishares Msci Brazil ETF vs Guardant Health Inc. Common Stock — how do they compare? Ishares Msci Brazil ETF trades at $43.5 (market cap $11.30B), while Guardant Health Inc. Common Stock trades at $168.65 (market cap $22.22B). The key difference: Guardant Health Inc. Common Stock is the larger of the two by market cap, and Ishares Msci Brazil ETF is trading nearer its 52-week high, Guardant Health Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ishares Msci Brazil ETF for 50 Days and Guardant Health Inc. Common Stock for 0 Days on average.
| EWZ | GH | |
|---|---|---|
Market Cap | $11.30B | $22.22B |
Volume | 44,036,597 | 1,589,453 |
Sector | Broad Market / Factor | Health |
52-Week High | $43.00 | $187.22 |
52-Week Low | $28.79 | $61.73 |
Typical Hold Time | 50 Days | 0 Days |
Enterprise Value | — | $22.86B |
Signals from Pluang's Aura AI — not financial advice
EWZ, the iShares MSCI Brazil ETF, trades at $43.14, up 1.82% with strong bullish momentum from moving averages but overbought RSI signals. The ETF shows unusual options activity and institutional interest, driven by Brazil's upcoming election and commodity exposure. Recent news highlights Wall Street positioning for potential policy shifts under different election outcomes, with the fund serving as a diversification tool from U.S. tech concentration.
Outlook remains election-dependent with asymmetric upside potential through call options. Risks include political volatility, U.S.-Brazil trade tensions, and currency fluctuations. The technical setup suggests near-term consolidation near pivot points while fundamentals rely on Brazil's economic policies and commodity performance.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →